POLB

Poolbeg Pharma PLC

GB Healthcare Biotechnology

Latest week
10 Jul 2026
Close
0.070000
Fair value
0.067847
Next-week expectancy
Undecided 49.93%
Sharemaestro

POLB Chart Pack

Poolbeg Pharma PLC

Exchange
LSE
Latest week
10 Jul 2026
Close
0.070000
Fair value
0.067847
Next-week expectancy
Undecided 49.93%
Generated
16 Jul 2026 17:21
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, POLB rose 53.85%, moving from 0.05 to 0.07. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 51.78 and has improved across the 12-week window. Market Dynamics is 0.90 on the latest week. Next-week expectancy is undecided at 49.93% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.07
12-Week Change
53.85%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.93%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
51.78
Market Dynamics
0.90

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.07
12-Week Change
53.85%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.93%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
51.78
Market Dynamics
0.90

Over the latest 12 completed weeks ending 2026-07-10, POLB rose 53.85%, moving from 0.05 to 0.07. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 51.78 and has improved across the 12-week window. Market Dynamics is 0.90 on the latest week. Next-week expectancy is undecided at 49.93% based on similar historical setup states.

Industry Peers

United Kingdom equities in Biotechnology

Stock Exchange Week Open High Low Close Change
IMM ImmuPharma plc LSE 10 Jul 2026 0.03 0.04 0.03 0.04 16.40%
IXI IXICO plc LSE 10 Jul 2026 0.08 0.10 0.08 0.09 12.12%
BSFA BSF Enterprise Plc LSE 10 Jul 2026 0.01 0.01 0.01 0.01 10.00%
SAR Sareum Holdings plc LSE 10 Jul 2026 0.21 0.24 0.20 0.23 9.52%
HEMO Hemogenyx Pharmaceuticals Plc LSE 10 Jul 2026 7.71 8.20 7.11 7.75 0.52%
APTA Aptamer Group PLC LSE 10 Jul 2026 0.00 0.01 0.00 0.00 0.00%
AREC Arecor Therapeutics plc LSE 10 Jul 2026 0.64 0.65 0.62 0.64 0.00%
PYC Physiomics Plc LSE 10 Jul 2026 0.00 0.01 0.00 0.00 0.00%
TCF Theracryf Plc LSE 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
THAT Thalia Therapeutics Plc LSE 10 Jul 2026 0.01 0.01 0.01 0.01 0.00%
PRTC PureTech Health plc LSE 10 Jul 2026 120.60 124.00 115.00 120.00 -0.50%
ONT Oxford Nanopore Technologies plc LSE 10 Jul 2026 121.00 128.70 111.90 120.30 -0.58%
OPTI OptiBiotix Health Plc LSE 10 Jul 2026 0.06 0.07 0.06 0.06 -0.78%
OXB Oxford Biomedica plc LSE 10 Jul 2026 617.00 623.22 581.00 611.00 -0.97%
FARN Faron Pharmaceuticals Oy LSE 10 Jul 2026 0.42 0.43 0.40 0.42 -1.19%
BVXP Bioventix PLC LSE 10 Jul 2026 1600.00 1650.00 1550.00 1580.00 -1.25%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.